Satellos Bioscience Inc. (TSX:MSCL)
Canada · Delayed Price · Currency is CAD 1.070
+0.130 (13.83%)
Jan 22, 2026, 3:57 PM EST
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of CAD 174.38 million as of January 22, 2026. Its market cap has increased by 22.28% in one year.
Market Cap
174.38M
Enterprise Value
126.16M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.07
Market Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from 58.83M to 174.38M, an increase of 196.40%. That is a compound annual growth rate of 27.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 174.38M | 42.42% |
| Dec 31, 2025 | 122.43M | -11.04% |
| Dec 31, 2024 | 137.63M | 183.77% |
| Dec 29, 2023 | 48.50M | 427.44% |
| Dec 30, 2022 | 9.20M | -72.13% |
| Dec 31, 2021 | 33.00M | -43.91% |
| Aug 19, 2021 | 58.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 631.58M |
| NervGen Pharma | 569.49M |
| Helix BioPharma | 165.74M |
| ME Therapeutics Holdings | 90.15M |
| Medicenna Therapeutics | 75.08M |
| Sharp Therapeutics | 72.18M |
| NurExone Biologic | 59.85M |
| Sernova Biotherapeutics | 53.87M |